{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:19:45Z","timestamp":1784996385906,"version":"3.55.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T00:00:00Z","timestamp":1425427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s40620-015-0186-0","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T07:59:36Z","timestamp":1425369576000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low"],"prefix":"10.1093","volume":"29","author":[{"given":"Jennifer L.","family":"Ennis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Worcester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredric L.","family":"Coe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,4]]},"reference":[{"key":"186_CR1","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/ndt\/gfs080","volume":"27","author":"J Ennis","year":"2012","unstructured":"Ennis J, Worcester E, Coe F (2012) Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD. Nephrol Dial Transplant 27:2847\u20132853","journal-title":"Nephrol Dial Transplant"},{"key":"186_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31\u201338","journal-title":"Kidney Int"},{"key":"186_CR3","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1097\/01.ASN.0000034202.91413.EB","volume":"13","author":"IH Boer De","year":"2002","unstructured":"De Boer IH, Gorodetskaya I, Young B, Hsu CY, Chertow GM (2002) The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol 13:2762\u20132769","journal-title":"J Am Soc Nephrol"},{"key":"186_CR4","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1053\/j.ajkd.2007.12.018","volume":"51","author":"JA Vassalotti","year":"2008","unstructured":"Vassalotti JA, Uribarri J, Chen SC et al (2008) Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999\u20132004. Am J Kidney Dis 51:S56\u2013S68","journal-title":"Am J Kidney Dis"},{"key":"186_CR5","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2008.4","volume":"73","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Isakova T, Andress DL, Levin A, Wolf M (2008) Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. Kidney Int 73:956\u2013962","journal-title":"Kidney Int"},{"key":"186_CR6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ndt\/6.3.162","volume":"6","author":"H Reichel","year":"1991","unstructured":"Reichel H, Deibert B, Schmidt-Gayk H, Ritz E (1991) Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplant 6:162\u2013169","journal-title":"Nephrol Dial Transplant"},{"key":"186_CR7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1046\/j.1523-1755.1999.0550031019.x","volume":"55","author":"E Ishimura","year":"1999","unstructured":"Ishimura E, Nishizawa Y, Inaba M et al (1999) Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55:1019\u20131027","journal-title":"Kidney Int"},{"key":"186_CR8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem-67-5-876","volume":"67","author":"TO Pitts","year":"1988","unstructured":"Pitts TO, Piraino BH, Mitro R et al (1988) Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab 67:876\u2013881","journal-title":"J Clin Endocrinol Metab"},{"key":"186_CR9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000098561","volume":"27","author":"AL Zisman","year":"2007","unstructured":"Zisman AL, Hristova M, Ho LT, Sprague SM (2007) Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 27:36\u201343","journal-title":"Am J Nephrol"},{"key":"186_CR10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0026-0495(78)90013-6","volume":"27","author":"IH Colodro","year":"1978","unstructured":"Colodro IH, Brickman AS, Coburn JW, Osborn TW, Norman AW (1978) Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure. Metabolism 27:745\u2013753","journal-title":"Metabolism"},{"key":"186_CR11","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(76)91140-5","volume":"2","author":"JB Eastwood","year":"1976","unstructured":"Eastwood JB, Stamp TC, Harris E, de Wardener HE (1976) Vitamin-D deficiency in the osteomalacia of chronic renal failure. Lancet 2:1209\u20131211","journal-title":"Lancet"},{"key":"186_CR12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","volume":"6","author":"P Kandula","year":"2011","unstructured":"Kandula P, Dobre M, Schold JD, Schreiber MJ Jr, Mehrotra R, Navaneethan SD (2011) Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 6:50\u201362","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 113","key":"186_CR13","first-page":"S1","volume":"76","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD). Kidney Int 76(Suppl 113):S1\u2013S130","journal-title":"Kidney Int"},{"key":"186_CR14","volume-title":"Dietary reference intakes for calcium and vitamin D","author":"Institute of Medicine (IOM)","year":"2011","unstructured":"Institute of Medicine (IOM) (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington, DC"},{"key":"186_CR15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1440-1797.2006.00698.x","volume":"11","author":"J DeVille","year":"2006","unstructured":"DeVille J, Thorp ML, Tobin L, Gray E, Johnson ES, Smith DH (2006) Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease. Nephrology (Carlton) 11:555\u2013559","journal-title":"Nephrology (Carlton)"},{"key":"186_CR16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ajkd.2007.04.010","volume":"50","author":"Z Al-Aly","year":"2007","unstructured":"Al-Aly Z, Qazi RA, Gonzalez EA, Zeringue A, Martin KJ (2007) Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 50:59\u201368","journal-title":"Am J Kidney Dis"},{"key":"186_CR17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000157177","volume":"31","author":"A Oksa","year":"2008","unstructured":"Oksa A, Spustova V, Krivosikova Z et al (2008) Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease. Kidney Blood Press Res 31:322\u2013329","journal-title":"Kidney Blood Press Res"},{"key":"186_CR18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/08860220801964210","volume":"30","author":"E Dogan","year":"2008","unstructured":"Dogan E, Erkoc R, Sayarlioglu H, Soyoral Y, Dulger H (2008) Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients. Ren Fail 30:407\u2013410","journal-title":"Ren Fail"},{"key":"186_CR19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4158\/EP.14.1.10","volume":"14","author":"P Chandra","year":"2008","unstructured":"Chandra P, Binongo JN, Ziegler TR et al (2008) Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 14:10\u201317","journal-title":"Endocr Pract"},{"key":"186_CR20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.07131009","volume":"5","author":"SM Moe","year":"2010","unstructured":"Moe SM, Saifullah A, LaClair RE, Usman SA, Yu Z (2010) A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease. Clin J Am Soc Nephrol 5:299\u2013306","journal-title":"Clin J Am Soc Nephrol"},{"key":"186_CR21","first-page":"885","volume":"93","author":"T Trakarnvanich","year":"2010","unstructured":"Trakarnvanich T, Chalapipat O, Disthabanchong S et al (2010) Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency. J Med Assoc Thai 93:885\u2013891","journal-title":"J Med Assoc Thai"},{"key":"186_CR22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5414\/CNP73276","volume":"73","author":"WY Qunibi","year":"2010","unstructured":"Qunibi WY, Abdellatif A, Sankar S et al (2010) Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K\/DOQI treatment guidelines adequate? Clin Nephrol 73:276\u2013285","journal-title":"Clin Nephrol"},{"key":"186_CR23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2011.06.027","volume":"59","author":"CP Kovesdy","year":"2012","unstructured":"Kovesdy CP, Lu JL, Malakauskas SM, Andress DL, Kalantar-Zadeh K, Ahmadzadeh S (2012) Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial. Am J Kidney Dis 59:58\u201366","journal-title":"Am J Kidney Dis"},{"key":"186_CR24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3945\/ajcn.112.040642","volume":"96","author":"JA Alvarez","year":"2012","unstructured":"Alvarez JA, Law J, Coakley KE et al (2012) High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 96:672\u2013679","journal-title":"Am J Clin Nutr"},{"key":"186_CR25","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/ndt\/gfs138","volume":"27","author":"P Marckmann","year":"2012","unstructured":"Marckmann P, Agerskov H, Thineshkumar S et al (2012) Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant 27:3523\u20133531","journal-title":"Nephrol Dial Transplant"},{"key":"186_CR26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266\u2013281","journal-title":"N Engl J Med"},{"key":"186_CR27","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","volume":"45","author":"RE LaClair","year":"2005","unstructured":"LaClair RE, Hellman RN, Karp SL et al (2005) Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45:1026\u20131033","journal-title":"Am J Kidney Dis"},{"key":"186_CR28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.ajkd.2011.12.035","volume":"60","author":"SU Nigwekar","year":"2012","unstructured":"Nigwekar SU, Bhan I, Thadhani R (2012) Ergocalciferol and cholecalciferol in CKD. Am J Kidney Dis 60:139\u2013156","journal-title":"Am J Kidney Dis"},{"key":"186_CR29","doi-asserted-by":"crossref","first-page":"c132","DOI":"10.1159\/000098645","volume":"105","author":"G Saab","year":"2007","unstructured":"Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW (2007) Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 105:c132\u2013c138","journal-title":"Nephron Clin Pract"},{"key":"186_CR30","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1093\/ndt\/gfn367","volume":"23","author":"F Tokmak","year":"2008","unstructured":"Tokmak F, Quack I, Schieren G et al (2008) High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant 23:4016\u20134020","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-015-0186-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-015-0186-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-015-0186-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:35Z","timestamp":1777564655000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/29\/1\/63\/8371427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,4]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1007\/s40620-015-0186-0","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,4]]}}}